Transmedics Group Inc
NASDAQ:TMDX
| Market Cap (Intraday) | 3.43B |
| Current PE | 70.06 |
| Forward PE | 61.12 |
| 2yr Forward PE | 44.28 |
| 10-Day MA | $124.87 |
| 50-Day MA | $123.39 |
| 200-Day MA | $95.27 |
Transmedics Group Inc Stock, NASDAQ:TMDX
200 Minuteman Road, Suite 302, Andover, Massachusetts 01810
United States of America
Phone: +1.978.552.0900
Number of Employees: 728
Description
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.